Schedule 13G ownership disclosure
Core Scientific Inc
Common Stock · CUSIP: 21874A106
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Valiant Capital Management, L.P.
Shares: 13,120,302.00 · Class: 4.2%
- Valiant Capital Management, LLC
Shares: 13,120,302.00 · Class: 4.2%
- Christopher R. Hansen
Shares: 13,120,302.00 · Class: 4.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-26-000075
- Form type
- SCHEDULE 13G/A
- Filer
- Core Scientific, Inc./tx
- CIK
- CIK 1839341
- Filed
- Feb 09, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership